Who owns Lexicon Pharmaceuticals?

Key details on Lexicon Pharmaceuticals (Ticker: LXRX)

Who owns Lexicon Pharmaceuticals?

Is LXRX a good stock to own? Find out who bought Lexicon Pharmaceuticals, who sold Lexicon Pharmaceuticals (LXRX) stock, and who holds a large position in Lexicon Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Artal Group S.A. 402.63M $378.47M March 31, 2015
FMR 107.08M $100.65M March 31, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 38.30M $35.62M March 31, 2015
Ulys 30.25M $28.43M March 31, 2015
Vanguard 19.06M $17.92M March 31, 2015
NEA Management Company 16.68M $15.68M March 31, 2015
BlackRock Fund Advisors 15.47M $14.54M March 31, 2015
Schroder Investment Management 8.82M $20.98M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 8.13M $7.64M March 31, 2015
Masters Capital Mgmt 7.96M $7.49M March 31, 2015
T. Rowe Price Associates 6.07M $5.53M Dec. 31, 2014
Royce & Associates 4.23M $7.32M March 31, 2014
Invus Public Equities Advisors 3.89M $6.85M June 30, 2011
STATE STREET CORPORATION 3.80M $3.57M March 31, 2015
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 3.71M $3.49M March 31, 2015
NORTHERN TRUST 3.50M $7.59M June 30, 2013